Actively Recruiting
Mind-body Medicine for Patients With Malignant Hematological Diseases
Led by Universität Duisburg-Essen · Updated on 2026-04-15
94
Participants Needed
1
Research Sites
486 weeks
Total Duration
On this page
Sponsors
U
Universität Duisburg-Essen
Lead Sponsor
R
Robert Bosch Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
This randomized controlled trial aims to investigate the effectiveness of a mind-body group program as a supprtivemanagement strategy for fatigue in patients with malignant hematological diseases.
CONDITIONS
Official Title
Mind-body Medicine for Patients With Malignant Hematological Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with malignant hematological diseases in complete remission after primary chemotherapy and/or radiation
- Physical and mental ability to attend 8 of 11 group sessions
You will not qualify if you...
- Receiving chemotherapy, radiation, or rehabilitation during the study period
- Pregnancy
- Participating in other studies with behavioral interventions during the study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Robert-Bosch-Krankenhaus, Abteilung für Hämatologie, Onkologie und Palliativmedizin
Stuttgart, Germany, 70376
Actively Recruiting
Research Team
H
Holger Cramer, PhD
CONTACT
H
Heidemarie Haller, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here